In patients with coronary artery disease endothelial function is associated with plasma levels of C-reactive protein and is improved by optimal medical therapy

Cristiana Vitale, Elena Cerquetani, Maurício Wajngarten, Filippo Leonardo, Antonello Silvestri, Giuseppe Mercuro, Massimo Fini, Josè Antonio Ramires, Giuseppe M C Rosano

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Background. Endothelial function is impaired in patients with coronary artery disease (CAD); in these patients plasma levels of C-reactive protein (CRP) and impaired endothelial function are related to future cardiac events. The aim of the present study was to evaluate the effects of medical therapy on endothelial function and CRP in patients with CAD. Methods. Seventy-three patients (52 men, 21 women, mean age 66 ± 9 years) with CAD and 32 control subjects (25 men, 7 women, mean age 65 ± 11 years) were enrolled in the study. The endothelial function was evaluated by means of flow-mediated dilation (FMD) of the brachial artery following ischemia and CRP by means of a high-sensitivity assay. After baseline evaluation of CRP and FMD all patients received full medical therapy for 3 months and were then again tested for endothelial function and CRP. Results. Compared to healthy controls, patients had significantly more impaired endothelial function (FMD 3.6 ± 3.2 vs 8 ± 2.4%, p <0.01) and higher CRP plasma levels (1.6 ± 0.9 vs 0.9 ± 0.56 mg/dl, p <0.05). At baseline a significant negative correlation was found between CRP plasma levels and FMD in patients with CAD (r = -0.56, p <0.05) while no correlation was found in controls. Medical therapy resulted in a significant improvement in endothelial function (3.64 ± 3 vs 7.2 ± 3.5%, p <0.01), and a decrease of CRP (-0.26 ± 0.19, p <0.01); the changes in CRP and FMD were independent of the drug used. A positive correlation was found between the improvement in FMD and the degree of CRP reduction (r = 0.57, p <0.01). Conclusions. In patients with CAD plasma levels of CRP are associated with an impaired endothelial function suggesting a correlation between inflammation and the integrity of the endothelium. Full medical therapy reduces CRP with a parallel improvement in endothelial function.

Original languageEnglish
Pages (from-to)627-632
Number of pages6
JournalItalian Heart Journal
Volume4
Issue number9
Publication statusPublished - 2003

Fingerprint

C-Reactive Protein
Coronary Artery Disease
Dilatation
Therapeutics
Brachial Artery
Endothelium
Ischemia
Inflammation

Keywords

  • Coronary artery disease
  • Inflammation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

In patients with coronary artery disease endothelial function is associated with plasma levels of C-reactive protein and is improved by optimal medical therapy. / Vitale, Cristiana; Cerquetani, Elena; Wajngarten, Maurício; Leonardo, Filippo; Silvestri, Antonello; Mercuro, Giuseppe; Fini, Massimo; Ramires, Josè Antonio; Rosano, Giuseppe M C.

In: Italian Heart Journal, Vol. 4, No. 9, 2003, p. 627-632.

Research output: Contribution to journalArticle

Vitale, Cristiana ; Cerquetani, Elena ; Wajngarten, Maurício ; Leonardo, Filippo ; Silvestri, Antonello ; Mercuro, Giuseppe ; Fini, Massimo ; Ramires, Josè Antonio ; Rosano, Giuseppe M C. / In patients with coronary artery disease endothelial function is associated with plasma levels of C-reactive protein and is improved by optimal medical therapy. In: Italian Heart Journal. 2003 ; Vol. 4, No. 9. pp. 627-632.
@article{02d476e9784a44fdbb9dc5f0cb8d8db9,
title = "In patients with coronary artery disease endothelial function is associated with plasma levels of C-reactive protein and is improved by optimal medical therapy",
abstract = "Background. Endothelial function is impaired in patients with coronary artery disease (CAD); in these patients plasma levels of C-reactive protein (CRP) and impaired endothelial function are related to future cardiac events. The aim of the present study was to evaluate the effects of medical therapy on endothelial function and CRP in patients with CAD. Methods. Seventy-three patients (52 men, 21 women, mean age 66 ± 9 years) with CAD and 32 control subjects (25 men, 7 women, mean age 65 ± 11 years) were enrolled in the study. The endothelial function was evaluated by means of flow-mediated dilation (FMD) of the brachial artery following ischemia and CRP by means of a high-sensitivity assay. After baseline evaluation of CRP and FMD all patients received full medical therapy for 3 months and were then again tested for endothelial function and CRP. Results. Compared to healthy controls, patients had significantly more impaired endothelial function (FMD 3.6 ± 3.2 vs 8 ± 2.4{\%}, p <0.01) and higher CRP plasma levels (1.6 ± 0.9 vs 0.9 ± 0.56 mg/dl, p <0.05). At baseline a significant negative correlation was found between CRP plasma levels and FMD in patients with CAD (r = -0.56, p <0.05) while no correlation was found in controls. Medical therapy resulted in a significant improvement in endothelial function (3.64 ± 3 vs 7.2 ± 3.5{\%}, p <0.01), and a decrease of CRP (-0.26 ± 0.19, p <0.01); the changes in CRP and FMD were independent of the drug used. A positive correlation was found between the improvement in FMD and the degree of CRP reduction (r = 0.57, p <0.01). Conclusions. In patients with CAD plasma levels of CRP are associated with an impaired endothelial function suggesting a correlation between inflammation and the integrity of the endothelium. Full medical therapy reduces CRP with a parallel improvement in endothelial function.",
keywords = "Coronary artery disease, Inflammation",
author = "Cristiana Vitale and Elena Cerquetani and Maur{\'i}cio Wajngarten and Filippo Leonardo and Antonello Silvestri and Giuseppe Mercuro and Massimo Fini and Ramires, {Jos{\`e} Antonio} and Rosano, {Giuseppe M C}",
year = "2003",
language = "English",
volume = "4",
pages = "627--632",
journal = "Italian Heart Journal",
issn = "1129-471X",
publisher = "Societa Italiana di Cardiologia",
number = "9",

}

TY - JOUR

T1 - In patients with coronary artery disease endothelial function is associated with plasma levels of C-reactive protein and is improved by optimal medical therapy

AU - Vitale, Cristiana

AU - Cerquetani, Elena

AU - Wajngarten, Maurício

AU - Leonardo, Filippo

AU - Silvestri, Antonello

AU - Mercuro, Giuseppe

AU - Fini, Massimo

AU - Ramires, Josè Antonio

AU - Rosano, Giuseppe M C

PY - 2003

Y1 - 2003

N2 - Background. Endothelial function is impaired in patients with coronary artery disease (CAD); in these patients plasma levels of C-reactive protein (CRP) and impaired endothelial function are related to future cardiac events. The aim of the present study was to evaluate the effects of medical therapy on endothelial function and CRP in patients with CAD. Methods. Seventy-three patients (52 men, 21 women, mean age 66 ± 9 years) with CAD and 32 control subjects (25 men, 7 women, mean age 65 ± 11 years) were enrolled in the study. The endothelial function was evaluated by means of flow-mediated dilation (FMD) of the brachial artery following ischemia and CRP by means of a high-sensitivity assay. After baseline evaluation of CRP and FMD all patients received full medical therapy for 3 months and were then again tested for endothelial function and CRP. Results. Compared to healthy controls, patients had significantly more impaired endothelial function (FMD 3.6 ± 3.2 vs 8 ± 2.4%, p <0.01) and higher CRP plasma levels (1.6 ± 0.9 vs 0.9 ± 0.56 mg/dl, p <0.05). At baseline a significant negative correlation was found between CRP plasma levels and FMD in patients with CAD (r = -0.56, p <0.05) while no correlation was found in controls. Medical therapy resulted in a significant improvement in endothelial function (3.64 ± 3 vs 7.2 ± 3.5%, p <0.01), and a decrease of CRP (-0.26 ± 0.19, p <0.01); the changes in CRP and FMD were independent of the drug used. A positive correlation was found between the improvement in FMD and the degree of CRP reduction (r = 0.57, p <0.01). Conclusions. In patients with CAD plasma levels of CRP are associated with an impaired endothelial function suggesting a correlation between inflammation and the integrity of the endothelium. Full medical therapy reduces CRP with a parallel improvement in endothelial function.

AB - Background. Endothelial function is impaired in patients with coronary artery disease (CAD); in these patients plasma levels of C-reactive protein (CRP) and impaired endothelial function are related to future cardiac events. The aim of the present study was to evaluate the effects of medical therapy on endothelial function and CRP in patients with CAD. Methods. Seventy-three patients (52 men, 21 women, mean age 66 ± 9 years) with CAD and 32 control subjects (25 men, 7 women, mean age 65 ± 11 years) were enrolled in the study. The endothelial function was evaluated by means of flow-mediated dilation (FMD) of the brachial artery following ischemia and CRP by means of a high-sensitivity assay. After baseline evaluation of CRP and FMD all patients received full medical therapy for 3 months and were then again tested for endothelial function and CRP. Results. Compared to healthy controls, patients had significantly more impaired endothelial function (FMD 3.6 ± 3.2 vs 8 ± 2.4%, p <0.01) and higher CRP plasma levels (1.6 ± 0.9 vs 0.9 ± 0.56 mg/dl, p <0.05). At baseline a significant negative correlation was found between CRP plasma levels and FMD in patients with CAD (r = -0.56, p <0.05) while no correlation was found in controls. Medical therapy resulted in a significant improvement in endothelial function (3.64 ± 3 vs 7.2 ± 3.5%, p <0.01), and a decrease of CRP (-0.26 ± 0.19, p <0.01); the changes in CRP and FMD were independent of the drug used. A positive correlation was found between the improvement in FMD and the degree of CRP reduction (r = 0.57, p <0.01). Conclusions. In patients with CAD plasma levels of CRP are associated with an impaired endothelial function suggesting a correlation between inflammation and the integrity of the endothelium. Full medical therapy reduces CRP with a parallel improvement in endothelial function.

KW - Coronary artery disease

KW - Inflammation

UR - http://www.scopus.com/inward/record.url?scp=2142683028&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2142683028&partnerID=8YFLogxK

M3 - Article

C2 - 14635381

AN - SCOPUS:2142683028

VL - 4

SP - 627

EP - 632

JO - Italian Heart Journal

JF - Italian Heart Journal

SN - 1129-471X

IS - 9

ER -